Fresenius SE KGaA (XSWX:FRE) Beneish M-Score: -2.84 (As of Jun. 24, 2026)


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF35.86
GF Value CHF32.85
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Beneish M-Score?

Fresenius SE KGaA XSWX:FRE 71 Beneish M-Score is -2.84 as of Jun. 24, 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF32.85 (Fairly Valued). The stock has 5 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 70.73% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.84 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Fresenius SE KGaA's Beneish M-Score or its related term are showing as below:

XSWX:FRE' s Beneish M-Score Range Over the Past 10 Years
Min: -3.58   Med: -2.59   Max: -1.55
Current: -2.84

During the past 13 years, the highest Beneish M-Score of Fresenius SE KGaA was -1.55. The lowest was -3.58. And the median was -2.59.


Fresenius SE KGaA Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Beneish M-Score Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.59 -2.63 -3.15 -2.76 -2.56

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.45 -2.24 -2.22 -2.56 -2.84

XSWX:FRE vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Beneish M-Score falls into.


XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Fresenius SE KGaA for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7224+0.528 * 1.0014+0.404 * 0.9745+0.892 * 1.0121+0.115 * 1.051
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0098+4.679 * -0.034823-0.327 * 0.9861
=-2.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was CHF3,606 Mil.
Revenue was 5295.389 + 5744.399 + 5125.127 + 5234.682 = CHF21,400 Mil.
Gross Profit was 1396.206 + 1422.103 + 1214.707 + 1367.527 = CHF5,401 Mil.
Total Current Assets was CHF10,984 Mil.
Total Assets was CHF38,564 Mil.
Property, Plant and Equipment(Net PPE) was CHF8,855 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF1,049 Mil.
Selling, General, & Admin. Expense(SGA) was CHF2,771 Mil.
Total Current Liabilities was CHF8,680 Mil.
Long-Term Debt & Capital Lease Obligation was CHF8,681 Mil.
Net Income was 395.925 + 336.863 + 321.43 + 309.522 = CHF1,364 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = CHF0 Mil.
Cash Flow from Operations was 354.057 + 1254.138 + 706.399 + 392.062 = CHF2,707 Mil.
Total Receivables was CHF4,932 Mil.
Revenue was 5450.618 + 5460.7 + 4997.634 + 5233.877 = CHF21,143 Mil.
Gross Profit was 1350.714 + 1344.402 + 1276.912 + 1371.006 = CHF5,343 Mil.
Total Current Assets was CHF11,375 Mil.
Total Assets was CHF41,273 Mil.
Property, Plant and Equipment(Net PPE) was CHF9,333 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF1,169 Mil.
Selling, General, & Admin. Expense(SGA) was CHF2,711 Mil.
Total Current Liabilities was CHF7,958 Mil.
Long-Term Debt & Capital Lease Obligation was CHF10,885 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3606.107 / 21399.597) / (4931.921 / 21142.829)
=0.168513 / 0.233267
=0.7224

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(5343.034 / 21142.829) / (5400.543 / 21399.597)
=0.252711 / 0.252367
=1.0014

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (10983.973 + 8855.077) / 38564.047) / (1 - (11375.037 + 9332.726) / 41273.195)
=0.485556 / 0.498276
=0.9745

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=21399.597 / 21142.829
=1.0121

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1168.819 / (1168.819 + 9332.726)) / (1048.868 / (1048.868 + 8855.077))
=0.1113 / 0.105904
=1.051

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2770.893 / 21399.597) / (2711.121 / 21142.829)
=0.129483 / 0.128229
=1.0098

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((8681.234 + 8680.324) / 38564.047) / ((10884.997 + 7958.131) / 41273.195)
=0.450201 / 0.456546
=0.9861

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1363.74 - 0 - 2706.656) / 38564.047
=-0.034823

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Fresenius SE KGaA has a M-score of -2.89 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.84 mean?
Fresenius SE KGaA (XSWX:FRE) has a Beneish M-Score of -2.84 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Fresenius SE KGaA and its competitors. According to the industry distribution chart, Fresenius SE KGaA ranks #185 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 29.3%.
Is Fresenius SE KGaA's Beneish M-Score too high?
Fresenius SE KGaA's current Beneish M-Score is -2.84. Based on the distribution chart, Fresenius SE KGaA ranks #185 out of 632 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #185 out of 632 companies for Beneish M-Score. This puts Fresenius SE KGaA in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Beneish M-Score is -2.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF32.85, compared to a current price of CHF35.86 — trading 9.2% above its estimated fair value. The current Beneish M-Score is -2.84. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Beneish M-Score is -2.84 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF35.86 is trading 9.2% above its estimated GF Value™ of CHF32.85. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • Beneish M-Score: -2.84
  • GF Value™: CHF32.85 vs. price of CHF35.86 (9.2% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF35.86
Price
CHF32.85
GF Value